Depression News and Research

Latest Depression News and Research

Research unlocks secrets of mouse behavior to help identify promising psychiatric drugs

Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.

25 Oct 2013

Study reveals that parental panic disorder affects children

Children of parents with anxiety disorders are more likely to develop anxiety disorders than children of normal controls . This familial aggregation is due to genetic and environmental influences, whereas it can be assumed that shared environmental influences have the greatest effects during childhood, decreasing with age.

24 Oct 2013

Neuropsychoanalysis Association to host conference on depression

The Neuropsychoanalysis Association is hosting a conference for researchers and clinicians on depression, "Towards a Real Understanding of Depression: Lessons from the Treatment Battlefeld and New Research," on Friday, November 1, 2013 from 9:00 am to 6:00 pm at the Icahn School of Medicine at Mount Sinai, The Bonnie and Kenneth Davis Auditorium, 1470 Madison Avenue (between 101st and 102nd Streets) in New York City.

24 Oct 2013

Postpartum diagnostic switches likely in depressed women

Women with major depression should be monitored for emerging symptoms of hypomania during the postpartum period, say researchers.

23 Oct 2013

Study examines effectiveness of musical therapy for mental health care clients

A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of music therapy in the mental health of patients

23 Oct 2013

Study of 2,400 children, teens and young adults sharpens focus on housing quality, not affordability

A new report from researchers at Boston College and Tufts University shows the distinct emotional and educational price children pay when their families live in run down apartments and homes.

23 Oct 2013

Study examines association between suicidal vulnerability and analgesic consumption in elderly

A paper published in the current issue of Psychotherapy and Psychosomatics has investigated the relationship between pain killers and suicidal behavior in the elderly.

23 Oct 2013

BRCA1/2 mutations may alter endometrial, ovarian function

Scientists have detected significant differences in endometrial thickness and hormone levels in women with and without BRCA1/2 mutations that may play a role in cancer susceptibility or development.

22 Oct 2013

Psychotherapy: New treatment choice for anorexia nervosa

A large-scale study has now shown that adult women with anorexia whose disorder is not too severe can be treated successfully on an out-patient basis. Even after conclusion of therapy, they continue to make significant weight gains.

22 Oct 2013

Professor wins Rhoda and Bernard Sarnat International Prize in Mental Health from Institute of Medicine

The Institute of Medicine today awarded the 2013 Rhoda and Bernard Sarnat International Prize in Mental Health to William T. Carpenter, professor of psychiatry and pharmacology at the University of Maryland School of Medicine, Baltimore.

22 Oct 2013

Astrazeneca, Evotec Launch Kidney Disease Collaboration

...

21 Oct 2013

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.

19 Oct 2013

Tips to overcome feelings of discouragement or blues

Whether it is simply waking up on the wrong side of the bed or a bad week at work, many situations may trigger an onset of the blues. One University of Alabama at Birmingham mental health expert says feeling down is a form of depression and should be addressed.

19 Oct 2013

CBT more effective in reducing symptoms of health anxiety

Cognitive behavioural therapy (CBT) is substantially more effective than standard care at reducing symptoms of health anxiety in medical patients, and can be delivered by non-specialist staff with minimal training at little extra cost.

19 Oct 2013

Improving wellness for people living with mood disorders from childhood throughout adulthood

The Depression and Bipolar Support Alliance and The Balanced Mind Foundation are joining forces to improve the mental health of, and facilitate wellness for, individuals living with mood disorders from childhood throughout adulthood.

18 Oct 2013

Prevalence of depression is twice high among migraineurs

The prevalence of depression among those with migraine is approximately twice as high as for those without the disease (men: 8.4% vs. 3.4%; women 12.4% vs. 5.7%), according to a new study published by University of Toronto researchers.

18 Oct 2013

Mixed state impedes remission in bipolar depression

Researchers highlight the importance of identifying sub-syndromal manic symptoms in patients experiencing an episode of bipolar depression after finding these less prominent symptoms lengthen the time to remission.

17 Oct 2013

Review article looks at recent research about insomnia among American soldiers

Various behavioral treatment options are helping to treat the sleeplessness experienced by one in every two American soldiers who have been deployed in recent military operations. So says Dr. Adam Bramoweth of the Department of Veterans Affairs Pittsburgh Healthcare System, and Dr. Anne Germain of the University of Pittsburgh School of Medicine in the US.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.

16 Oct 2013